Top Core and Group Health Stories
Arena slips as it waits for ruling on weight drug
By Associated PressArena Pharmaceuticals Inc. reported a smaller fourth-quarter loss Monday, but said it is still waiting for federal regulators to make a decision about the status of its weight loss drug Belviq.
